This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Orano Med. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Tania Stallons: Innovator in PSMA-Targeting Conjugates
Introduction
Tania Stallons is a notable inventor based in Wylie, TX (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of PSMA-targeting conjugates. Her work is essential for advancing medical treatments and improving patient outcomes.
Latest Patents
Tania Stallons holds a patent for a PSMA-targeting conjugate and its uses. This invention involves a PSMA-targeting conjugate or a pharmaceutically acceptable salt that can be utilized for preparing a radiopharmaceutical. Once labeled with a radionuclide, it serves as a radiopharmaceutical. The conjugate is represented by the formula (I): A-L-Ch-L-A(I), where Ch is a chelator, L and L are linkers, and A and A are urea-based PSMA ligands. This innovative approach has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Tania Stallons is currently associated with Orano Med, where she continues to work on groundbreaking research and development in the pharmaceutical sector. Her expertise and dedication have positioned her as a key player in her field.
Collaborations
Tania collaborates with talented professionals such as Julien Torgue and Amy Wong. Their combined efforts contribute to the advancement of innovative solutions in medical science.
Conclusion
Tania Stallons is a pioneering inventor whose work on PSMA-targeting conjugates is making a significant impact in the pharmaceutical industry. Her contributions are vital for the future of targeted cancer therapies.